Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer

Kenji Morimoto,Tadaaki Yamada,Takashi Yokoi,Takashi Kijima,Yasuhiro Goto,Akira Nakao,Makoto Hibino,Takayuki Takeda,Hiroyuki Yamaguchi,Chieko Takumi,Masafumi Takeshita,Yusuke Chihara,Takahiro Yamada,Osamu Hiranuma,Yoshie Morimoto,Masahiro Iwasaku,Yoshiko Kaneko,Junji Uchino,Koichi Takayama

Lung Cancer（2021）

Cited 24|Views50

No score

Abstract

•A retrospective study on older patients with non-small-cell lung cancer was conducted.•Clinical impact of pembrolizumab plus chemotherapy was studied in these patients.•Pembrolizumab combined with platinum and pemetrexed leads to poor clinical outcomes.•Poor performance status and low albumin level were prognostic factors.

Translated text

Key words

Non-small-cell lung cancer,Pembrolizumab,Pemetrexed,Age,Immunochemotherapy,Chemoimmunotherapy

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined